Skip to content
Healthcare, Pharmaceuticals & Life Sciences →

Pharmaceuticals & Bulk Drugs Regulations, DPCO & API Policy Updates

Daily notifications on Drugs & Cosmetics Act amendments, NPPA drug price control orders (DPCO), Bulk Drug Parks, and API PLI schemes.

Coverage: Central & State Gazette Notifications
Cadence: Daily Real-Time Updates

Pharmaceuticals & Bulk Drugs Regulatory Landscape & Compliance Overview

Official Intelligence

PolicyIndex indexes real-time gazette notifications, policy orders, tariff determinations, and compliance circulars issued across the Pharmaceuticals & Bulk Drugs sector. Regulatory intelligence is aggregated across central ministries, state regulatory commissions, and statutory authorities.

Statutory Directives

Official Extraordinary Gazettes, S.O. & G.S.R. orders, and executive notifications.

Compliance Mandates

Sector-specific regulatory obligations, licensing norms, and statutory filing guidelines.

Key Focus Areas: drugs cosmetics act dpco price ceiling nppa bulk drug park scheme api pli scheme clinical trial rules india

Other Verticals in Healthcare, Pharmaceuticals & Life Sciences

AYUSH & Nutraceuticals Hospitals & Digital Health Medical Devices & Diagnostics
Strategic Intelligence

Looking for Weekly Policy & Regulatory Briefings?

Access curated sector roundups, executive summaries, and downloadable PDF intelligence reports.

Browse Weekly Roundups →

Latest Pharmaceuticals & Bulk Drugs News & Analysis

Pharmaceuticals & Bulk Drugs

Health Ministry Moves Four Neurological Drugs to Schedule H1 List

The Health Ministry has issued draft rules adding Flupentixol, Zopiclone, Gabapentin, and Carisoprodol to Schedule H1 of the Drugs Rules, 19...

By Policy & Regulatory Editorial Desk 2026-08-22

Official Pharmaceuticals & Bulk Drugs Gazettes & Notifications

Frequently Asked Questions on Pharmaceuticals & Bulk Drugs Regulations

What is the function of NPPA in drug pricing?

The National Pharmaceutical Pricing Authority (NPPA) fixes and revises prices of controlled bulk drugs and formulations under the DPCO to ensure drug affordability.